| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:51:59 UTC |
|---|
| HMDB ID | HMDB0015461 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Glycodiazine |
|---|
| Description | Glycodiazine is used with diet to lower blood glucose by increasing the secretion of insulin from pancreas and increasing the sensitivity of peripheral tissues to insulin. The mechanism of action of glycodiazine in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells, and increasing sensitivity of peripheral tissues to insulin. Glycodiazine likely binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-sensitive calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin. It is used for the concomitant use with insulin for the treatment of noninsulin-dependent (type 2) diabetes mellitus. |
|---|
| Structure | COCCOC1=CN=C(NS(=O)(=O)C2=CC=CC=C2)N=C1 InChI=1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12/h2-6,9-10H,7-8H2,1H3,(H,14,15,16) |
|---|
| Synonyms | | Value | Source |
|---|
| 2-Benzenesulfonamido-5-(2-methoxyethoxy)pyrimidine | ChEBI | | Glidiazine | ChEBI | | Glymidinum | ChEBI | | 2-Benzenesulphonamido-5-(2-methoxyethoxy)pyrimidine | Generator | | Glymidine | HMDB | | N-[5-(2-Methoxyethoxy)pyrimidin-2-yl]benzenesulphonamide | HMDB | | Glycodiazine | MeSH |
|
|---|
| Chemical Formula | C13H15N3O4S |
|---|
| Average Molecular Weight | 309.341 |
|---|
| Monoisotopic Molecular Weight | 309.078326673 |
|---|
| IUPAC Name | N-[5-(2-methoxyethoxy)pyrimidin-2-yl]benzenesulfonamide |
|---|
| Traditional Name | glycodiazine |
|---|
| CAS Registry Number | 339-44-6 |
|---|
| SMILES | COCCOC1=CN=C(NS(=O)(=O)C2=CC=CC=C2)N=C1 |
|---|
| InChI Identifier | InChI=1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12/h2-6,9-10H,7-8H2,1H3,(H,14,15,16) |
|---|
| InChI Key | QFWPJPIVLCBXFJ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzenesulfonamides |
|---|
| Direct Parent | Benzenesulfonamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzenesulfonamide
- Benzenesulfonyl group
- Alkyl aryl ether
- Pyrimidine
- Organosulfonic acid amide
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Sulfonyl
- Aminosulfonyl compound
- Heteroaromatic compound
- Dialkyl ether
- Organoheterocyclic compound
- Azacycle
- Ether
- Organic oxygen compound
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.12 g/L | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.59 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.4115 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.79 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1978.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 308.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 146.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 176.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 86.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 430.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 637.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 74.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1023.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 381.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1363.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 311.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 345.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 343.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 191.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 96.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Glycodiazine,1TMS,isomer #1 | COCCOC1=CN=C(N([Si](C)(C)C)S(=O)(=O)C2=CC=CC=C2)N=C1 | 2520.7 | Semi standard non polar | 33892256 | | Glycodiazine,1TMS,isomer #1 | COCCOC1=CN=C(N([Si](C)(C)C)S(=O)(=O)C2=CC=CC=C2)N=C1 | 2390.8 | Standard non polar | 33892256 | | Glycodiazine,1TMS,isomer #1 | COCCOC1=CN=C(N([Si](C)(C)C)S(=O)(=O)C2=CC=CC=C2)N=C1 | 3696.0 | Standard polar | 33892256 | | Glycodiazine,1TBDMS,isomer #1 | COCCOC1=CN=C(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=CC=C2)N=C1 | 2781.6 | Semi standard non polar | 33892256 | | Glycodiazine,1TBDMS,isomer #1 | COCCOC1=CN=C(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=CC=C2)N=C1 | 2597.4 | Standard non polar | 33892256 | | Glycodiazine,1TBDMS,isomer #1 | COCCOC1=CN=C(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=CC=C2)N=C1 | 3700.8 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Glycodiazine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00kb-9770000000-ea6c0b6ca2cdf199cf0b | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Glycodiazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Glycodiazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 10V, Positive-QTOF | splash10-03di-1539000000-cad8a53e4094d40387f1 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 20V, Positive-QTOF | splash10-0k96-6922000000-cf7c45f02c1c50bf26e6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 40V, Positive-QTOF | splash10-02vi-9310000000-6463cc4b55dbc70dc51e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 10V, Negative-QTOF | splash10-0a4i-0149000000-b06862f8e17b75fb66e2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 20V, Negative-QTOF | splash10-0kai-1961000000-9d7ab1d9bbe75471d3f9 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 40V, Negative-QTOF | splash10-003u-4910000000-0bafe7ba5932a7189116 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 10V, Positive-QTOF | splash10-03di-0009000000-454a20f41f470b743b2d | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 20V, Positive-QTOF | splash10-03di-0319000000-dd30359a3347b4f1d3e1 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 40V, Positive-QTOF | splash10-06vm-4921000000-ec2a33f6dbe52eca5bea | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 10V, Negative-QTOF | splash10-0a4i-0029000000-cf79580c51558359ef5d | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 20V, Negative-QTOF | splash10-0zfr-0890000000-1c58185ace70bb715004 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycodiazine 40V, Negative-QTOF | splash10-0bu0-0900000000-dd2cbfd0834f41e05057 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|